These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 9240645

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C.
    Berger C, Chapet S, Reynaud-Bougnoux A, Garand G, Le Floch O, Calais G.
    Eur J Cancer; 1996 Sep; 32A(10):1707-11. PubMed ID: 8983278
    [Abstract] [Full Text] [Related]

  • 23. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
    Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):134-9. PubMed ID: 12007951
    [Abstract] [Full Text] [Related]

  • 24. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.
    Tessa M, Rotta P, Ragona R, Sola B, Grassini M, Nassisi D, Sciacero P, Airoldi M, Filippi A, Gianello L, De Angelis C, Ozzello F, Trotti AB, Ricardi U, Sannazzari GL.
    Tumori; 2005 May 01; 91(5):406-14. PubMed ID: 16459637
    [Abstract] [Full Text] [Related]

  • 25. High dose rate brachytherapy for superficial cancer of the esophagus.
    Maingon P, d'Hombres A, Truc G, Barillot I, Michiels C, Bedenne L, Horiot JC.
    Int J Radiat Oncol Biol Phys; 2000 Jan 01; 46(1):71-6. PubMed ID: 10656375
    [Abstract] [Full Text] [Related]

  • 26. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE, Winter K, Kocha WI, Pinover WH, Herskovic, Graham M, Gunderson L.
    Cancer J; 2001 Jan 01; 7(5):388-94. PubMed ID: 11693897
    [Abstract] [Full Text] [Related]

  • 29. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A, Fukada J, Kota R, Koike N, Shiraishi Y, Seki S, Yoshida K, Kitagawa Y, Shigematsu N.
    Dis Esophagus; 2018 Apr 01; 31(4):. PubMed ID: 29228166
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study.
    Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, Nikolic N.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1061-6. PubMed ID: 9539560
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy.
    Allal AS, Obradovic M, Laurencet F, Roth AD, Spada A, Marti MC, Kurtz JM.
    Cancer; 1999 Jan 01; 85(1):26-31. PubMed ID: 9921970
    [Abstract] [Full Text] [Related]

  • 34. Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies.
    Grigsby PW, Graham MV, Perez CA, Galakatos AE, Camel HM, Kao MS.
    Am J Clin Oncol; 1996 Feb 01; 19(1):1-6. PubMed ID: 8554027
    [Abstract] [Full Text] [Related]

  • 35. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 36. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y, Bowen MG, Van Nagell JR, Gallion HH, DePriest P, Wierzbicki J.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):529-34. PubMed ID: 8005811
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.